Internal Medicine Doctors in South Salt Lake, UT Accepting Medicare
6 Internal Medicine doctors found. Showing 1 - 6
 Kevin L Jansen, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 |
Dr. Max Parkanzky, DVM, MS, DACVIM Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 331 W Bearcat Dr, South Salt Lake, UT 84115 Phone: 385-341-4444 |
 Danyi Zheng, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 |
Dr. Ruth Merry Indahyung, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 |
Dr. James Shaffner, D.O. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 |
Arasu Gopinath, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 |
News Archive
New report examines donor funding for health in low and middle income countries
With the U.S. poised to reauthorize the President's Emergency Plan for AIDS Relief (PEPFAR) and almost triple its financing over the next five years, a new report from the Kaiser Family Foundation looks at trends in health funding provided by donor governments to low- and middle- income countries.
UMass Medical School licenses "anti-gal" technology to Agalimmune
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
Teva Pharmaceutical Industries reaches settlement in principle to resolve claims under federal, state False Claims Acts
Teva Pharmaceutical Industries Ltd. announced today that several of its subsidiaries in the United States reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, Inc. on behalf of the United States, Texas, Florida, and California under federal and state False Claims Acts.
NIH awards grant to discover drug for alcoholism
With the ultimate goal to discover a drug that one day treats alcoholism, a University of Houston (UH) pharmacy professor is working on pinpointing the mechanisms in the brain that respond to alcohol.
Hip procedures during busy periods have worse outcomes
Hip fractures are serious, especially for the elderly. The operation can be a great strain, and 13 per cent of patients over the age of 70 treated in Norwegian hospitalsdo not survive 60 days after the fracture.
› Verified 1 days ago